N-propionyl-3-aminodihydro-2(3h)-thiophenone

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-propionyl-3-aminodihydro-2(3h)-thiophenone
• 英文别名: N-(2-oxothiolan-3-yl)propanamide
• 化学式: C₇H₁₁NO₂S
• 分子量: 173.24
• InChiKey: BAXRWZGFHHYVQE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  71.5
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• [EN] PROCESS FOR TREATING KERATIN MATERIALS USING A COMPOSITION COMPRISING A COMPOUND OF THIOLACTONE TYPE AND A COMPOSITION COMPRISING AN ALKALINE AGENT AND/OR AN AMINO DERIVATIVE OF ALKOXYSILANE<br/>[FR] PROCÉDÉ DE TRAITEMENT DE MATIÈRES KÉRATINIQUES PAR L'UTILISATION D'UNE COMPOSITION COMPRENANT UN COMPOSÉ DE TYPE THIOLACTONE ET D'UNE COMPOSITION COMPRENANT UN AGENT ALCALIN ET/OU UN DÉRIVÉ AMINÉ D'ALKOXYSILANE
  申请人：OREAL

  公开号：WO2018115258A1

  公开（公告）日：2018-06-28

  The present invention relates to a process for treating keratin materials, in particular the hair, using a first composition comprising one or more alkaline agents and/or one or more amino derivatives of alkoxysilane and a second composition comprising one or more compound(s) of thiolactone type.

  本发明涉及一种处理角蛋白质材料的方法，特别是使用第一组分包括一种或多种碱性剂和/或一种或多种氨基烷氧基硅烷衍生物以及第二组分包括一种或多种硫内酯类化合物，来处理头发。
• METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS
  申请人：Janssen Pharmaceutica NV

  公开号：EP1332133B1

  公开（公告）日：2008-07-09
• TREATING, PREVENTING OR AMELIORATING A HYPERPROLIFERATIVE DISEASE/DISORDER
  申请人：Klopman Gilles

  公开号：US20110082148A1

  公开（公告）日：2011-04-07

  The invention provides a method for treating, preventing or ameliorating a hyperproliferative disease and/or disorder such as cancer (e.g. leukemia) in a mammal comprising administering a therapeutically effective amount of one or more compounds selected from the group consisting of compounds of Formula (I), quinolones and fluoroquinolones; or a pharmaceutically acceptable salt thereof to said mammal: wherein R 1 comprises a structural moiety represented by X—C(O)—CH—NH(X═O or S). The invention also provides a combination therapy method using such compounds in combination with other cancer fighting chemicals. The invention exhibits merits such as none or minimal side effect associated with chemotherapy.
• US7517517B2
  申请人：——

  公开号：US7517517B2

  公开（公告）日：2009-04-14
• US7629468B2
  申请人：——

  公开号：US7629468B2

  公开（公告）日：2009-12-08